Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2017 · Clinical Cancer Research · 19 citations
https://doi.org/10.1158/1078-0432.ccr-17-1983
P
Pei-Yin Hsu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
820
Citations
15
h-index
17
i10-index
Pei-Yin Hsu is an academic researcher from City Of Hope National Medical Center. The author has contributed to research in topics: Epigenetics and DNA Methylation & Genomics and Chromatin Dynamics & Gene expression and cancer classification. The author has an h-index of 15, co-authored 15 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat